• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Predictive Genetic Testing and Consumer Wellness Genomics Market Size

    ID: MRFR/LS/9360-HCR
    120 Pages
    Rahul Gotadki
    October 2025

    Predictive Genetic Testing & Consumer/Wellness Genomics Market Research Report Information by Test Type (Predictive Testing [Genetic Susceptibility Test, Predictive Diagnostic, and Population Screening], Consumer Genomics, and Wellness Genomics [Nutria Genetic, Skin & Metabolism Genetics, and Others], by Application (Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screen...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    ReportInfographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Predictive Genetic Testing And Consumer Wellness Genomics Size

    Predictive Genetic Testing and Consumer Wellness Genomics Market Growth Projections and Opportunities

    Consumer desire in customized health information drives predictive genetic testing and consumer wellness genomics. People research their genetic predispositions to reduce illness risk, optimize lifestyle choices, and manage their health.

    This market grows due to genetic technology advances. Advanced bioinformatics and high-throughput sequencing offer more accurate genetic testing. Predictive genetic testing and wellness genomics services become more affordable as genomic sequencing costs fall.

    Increased consumer understanding of genetics in health affects the market. Media coverage, education, and healthcare advocacy help people realize how genetic testing might forecast illness vulnerability and implement preventative or early intervention actions.

    Consumers may actively engage in healthcare decisions using predictive genetic testing. Understanding genetic predispositions helps people make lifestyle, preventive, and healthcare decisions. This customized decision-making trend pushes predictive genetic testing and wellness genomics. The popularity of direct-to-consumer genetic testing services drives market growth. Consumers can get genetic insights without healthcare intermediaries from at-home testing kits. It gives customers a more direct and customized contact with their genetic data.

    Genomic data complexity requires specialized interpretation services. Companies offering comprehensive and easy-to-use genomic data interpretation tools see demand. The market responds with sophisticated algorithms and platforms that provide actionable insights, improving predictive genetic testing and wellness genomics. The digital health trend drives predictive genetic testing and wellness genomics integration with digital health platforms. Integration with mobile apps, wearables, and other digital health tools improves the consumer experience and lets people use genetic insights in their daily routines. The global shift toward preventive healthcare makes predictive genetic testing more important. People are increasingly interested in genetic markers linked to lifestyle-preventable diseases. Genetic testing services support proactive health management, aligning with this prevention focus. Genetic testing ethics and privacy affect the market. Data security and privacy awareness affects consumer testing willingness. Companies that address these concerns with transparency and strong privacy measures gain an edge in predictive genetic testing and consumer wellness genomics. Research and collaborations between genetic testing companies, healthcare providers, and research institutions drive market growth. Scientific advances, new genetic markers, and collaborative efforts to expand predictive genetic testing applications improve consumer value.

    Market Summary

    Key Market Trends & Highlights

    Market Trends

    Predictive Genetic Testing and Consumer Wellness Genomics Market Market Drivers

    Market Segment Insights

    Regional Insights

    Industry Developments

      • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics
      • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
      • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
      • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
      • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.

    Market Segmentation

    Europe

    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    Asia-Pacific

    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    By Test Type

    • Predictive Testing
    • Consumer Genomics
    • Wellness Genomics

    North America

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    By Setting Type

    • Proteomic Testing
    • Metabolic Testing
    • Genomic Testing

    Rest of the World

    • Middle East
    • Africa
    • Latin America 

    By Application type

    • Breast & Ovarian Cancer
    • Cardiovascular Screening
    • Colon Cancer
    • Others

    List of companies covered in this report:

    • 23andMe, Inc. (California)
    • Myriad Genetics, Inc. (US)
    • Hoffmann-La Roche Ltd. (Switzerland)
    • Abbott Laboratories (US)
    • Genesis Genetics (US)
    • Agilent Technologies (US)
    • Thermo Fisher Scientific, Inc. (US)
    • Bureau Gravimétrique International (China)
    • Bio-Rad Laboratories Inc. (US)
    • Illumina, Inc. (US)
    • Counsyl, Inc. (California)
    • ARUP Laboratories  (US)
    • Others

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Region

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    Predictive Genetic Testing & Consumer/Wellness Genomics Recent Developments

    • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.
    • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
    • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
    • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
    • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Test Type

    • Wellness Genomics
    • Nutria Genetic
    • Skin & Metabolism Genetics
    • Others
    • Consumer Genomics
    • Predictive Testing
    • Genetic Susceptibility Test
    • Predictive Diagnostic
    • Population Screening

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Application

    • Breast & Ovarian Cancer
    • Cardiovascular Screening
    • Diabetic Screening & Monitoring
    • Colon Cancer
    • Parkinsonism/Alzheimer’s Disease
    • Urologic Screening/Prostate Cancer Screening
    • Orthopedic & Musculoskeletal
    • Others

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Setting Type

    • Proteomic Testing
    • Metabolic Testing
    • Genomic Testing

    Report Scope

    Report Attribute/Metric Details
      Market Size   USD 11.2 Billion
      CAGR   5.4%
      Base Year   2022
      Forecast Period   2023-2032
      Historical Data   2021
      Forecast Units   Value (USD Billion)
      Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Test Type, Application, and Setting Type
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World
      Key Vendors   23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US)
      Key Market Opportunities   Rise of application in personalized medicine
      Key Market Drivers   Usage of predictive genetic testing & consumer/wellness genomics in various applications

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    How Big is the Predictive Genetic Testing & Consumer/Wellness Genomics market?

    The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 5.4 billion by 2032 at 11.2% CAGR during the forecast period (2023 - 2032)

    Who are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

    23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

    Which region is predicted to have the largest market share of Predictive Genetic Testing & Consumer/Wellness Genomics?

    North America holds the largest share in the global market of Predictive Genetic Testing & Consumer/Wellness Genomics

    What are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

    Usage of predictive genetic testing & consumer/wellness genomics in various applications and Rising R&D initiatives for novel therapeutics are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

    Which factors may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics?

    High cost of genomic research instruments and Inadequate funding and lack of trained professionals may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics

    1. . EXECUTIVE SUMMARY
    2. . MARKET INTRODUCTION
    3. . Definition
    4. . Scope of the Study
    5. . Research Objective
    6. . Assumptions
    7. . Limitations
    8. . RESEARCH METHODOLOGY
    9. . Overview
    10. . Data Mining
    11. . Secondary Research
    12. . Primary Research
    13. . Primary Interviews and Information Gathering Process
    14. . Breakdown of Primary Respondents
    15. . Forecasting Application
    16. . Market Size Estimation
    17. . Bottom-Up Approach
    18. . Top-Down Approach
    19. . Data Triangulation
    20. . Validation
    21. . MARKET DYNAMICS
    22. . Overview
    23. . Drivers
    24. . Restraints
    25. . Opportunities
    26. . MARKET FACTOR ANALYSIS
    27. . Porter’s Five Forces Analysis
    28. . Bargaining Power of Suppliers
    29. . Bargaining Power of Buyers
    30. . Threat of New Entrants
    31. . Threat of Substitutes
    32. . Intensity of Rivalry
    33. . Value Chain Analysis
    34. . COVID-19 Impact Analysis
    35. . Market Impact Analysis
    36. . Impact on Supply Chain
    37. . Regional Impact
    38. . Opportunity and Threat Analysis
    39. . GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE
    40. . Overview
    41. . Predictive Testing
    42. . Genetic Susceptibility Test
    43. . Predictive Diagnostic
    44. . Population Screening
    45. . Consumer Genomics
    46. . Wellness Genomics
    47. . Nutria Genetic
    48. . Skin & Metabolism Genetics
    49. . Others
    50. . GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION
    51. . Overview
    52. . Breast & Ovarian Cancer
    53. . Cardiovascular Screening
    54. . Diabetic Screening & Monitoring
    55. . Colon Cancer
    56. . Parkinsonism/Alzheimer’s Disease
    57. . Urologic Screening/Prostate Cancer Screening
    58. . Orthopedic & Musculoskeletal
    59. . Others
    60. . GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE
    61. . Overview
    62. . Proteomic Testing
    63. . Metabolic Testing
    64. . Genomic Testing
    65. . GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY REGION
    66. . Overview
    67. . North America
    68. . US
    69. . Canada
    70. . Europe
    71. . Germany
    72. . France
    73. . UK
    74. . Italy
    75. . Spain
    76. . Rest of Europe
    77. . Asia-Pacific
    78. . China
    79. . India
    80. . Japan
    81. . South Korea
    82. . Australia
    83. . Rest of Asia-Pacific
    84. . Rest of the World
    85. . Middle East
    86. . Africa
    87. . Latin America
    88. . COMPANY LANDSCAPE
    89. . Overview
    90. . Competitive Analysis
    91. . Market Share Analysis
    92. . Major Growth Strategy in the Global Predictive Genetic Testing & Consumer/Wellness Genomics Market
    93. . Competitive Benchmarking
    94. . Leading Players in Terms of Number of Developments in the Global Predictive Genetic Testing & Consumer/Wellness Genomics Market
    95. . Key developments and Growth Strategies
    96. . New Product Launch/Service Deployment
    97. . Merger & Acquisitions
    98. . Joint Ventures
    99. . Major Players
    100. . Sales & Operating Income, 2020
    101. . Major Players R&D Expenditure. 2020
    102. . COMPANY PROFILES
    103. . 23andMe, Inc.
    104. . Company Overview
    105. . Financial Overview
    106. . Products Offered
    107. . Key Developments
    108. . SWOT Analysis
    109. . Key Strategies
    110. . Myriad Genetics, Inc.
    111. . F.Hoffmann-La Roche Ltd.
    112. . Abbott Laboratories
    113. . Genesis Genetics
    114. . Agilent Technologies
    115. . Thermo Fisher Scientific, Inc.
    116. . Bureau Gravimétrique International
    117. . Bio-Rad Laboratories Inc.
    118. . Illumina, Inc.
    119. . Counsyl, Inc.
    120. . ARUP Laboratories
    121. . Others
    122. . APPENDIX
    123. . References
    124. . Related Reports LIST OF TABLES TABLE 1 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SYNOPSIS, 2023–2032 TABLE 2 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET ESTIMATES & FORECAST, 2023–2032 (USD MILLION) TABLE 3 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 4 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 5 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 6 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 7 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 8 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 9 US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 10 US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 11 US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 12 CANADA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 13 CANADA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 14 CANADA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 15 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 1 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 2 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 3 GERMANY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 4 GERMANY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 5 GERMANY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 6 FRANCE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 7 FRANCE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 8 FRANCE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 9 ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 10 ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 11 ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 12 SPAIN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 13 SPAIN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 14 SPAIN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 15 UK: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 16 UK: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 17 UK: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 18 REST OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 19 REST OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 20 REST OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 21 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 22 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 23 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 24 JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 25 JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 26 JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 27 CHINA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 28 CHINA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 29 CHINA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 30 INDIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 31 INDIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 32 INDIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 33 AUSTRALIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 34 AUSTRALIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 35 AUSTRALIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 36 SOUTH KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 37 SOUTH KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 38 SOUTH KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 39 REST OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 40 REST OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 41 REST OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 42 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 43 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 44 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 45 MIDDLE EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 46 MIDDLE EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 47 MIDDLE EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 48 AFRICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 49 AFRICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 50 AFRICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) TABLE 51 LATIN AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION) TABLE 52 LATIN AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION) TABLE 53 LATIN AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) LIST OF FIGURES FIGURE 1 RESEARCH PROCESS FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET FIGURE 4 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY TEST TYPE, 2020 (%) FIGURE 5 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY APPLICATION, 2020 (%) FIGURE 6 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY SETTING TYPE, 2020 (%) FIGURE 7 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 8 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 9 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 10 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 11 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 12 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET: COMPANY SHARE ANALYSIS, 2020 (%) FIGURE 13 23ANDME, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 14 23ANDME, INC.: SWOT ANALYSIS FIGURE 15 MYRIAD GENETICS, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 16 MYRIAD GENETICS INC.: SWOT ANALYSIS FIGURE 17 F.HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 18 F.HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS FIGURE 19 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT FIGURE 20 ABBOTT LABORATORIES: SWOT ANALYSIS FIGURE 21 GENESIS GENETICS: FINANCIAL OVERVIEW SNAPSHOT FIGURE 22 GENESIS GENETICS: SWOT ANALYSIS FIGURE 23 AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT FIGURE 24 AGILENT TECHNOLOGIES: SWOT ANALYSIS FIGURE 25 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 26 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS FIGURE 27 BUREAU GRAVIMÉTRIQUE INTERNATIONAL: FINANCIAL OVERVIEW SNAPSHOT FIGURE 28 BUREAU GRAVIMÉTRIQUE INTERNATIONAL: SWOT ANALYSIS FIGURE 29 BIO-RAD LABORATORIES INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 30 BIO-RAD LABORATORIES INC..: SWOT ANALYSIS FIGURE 31 ILLUMINA, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 32 ILLUMINA, INC.: SWOT ANALYSIS FIGURE 33 COUNSYL, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 34 COUNSYL, INC.: SWOT ANALYSIS FIGURE 35 ARUP LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT FIGURE 36 ARUP LABORATORIES: SWOT ANALYSIS
    125. List of Tables and Figures
      1. Table FIGURE 1 RESEARCH PROCESS FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET FIGURE 4 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY TEST TYPE, 2020 (%) FIGURE 5 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY APPLICATION, 2020 (%) FIGURE 6 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY SETTING TYPE, 2020 (%) FIGURE 7 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 8 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 9 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 10 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 11 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 12 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET: COMPANY SHARE ANALYSIS, 2020 (%) FIGURE 13 23ANDME, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 14 23ANDME, INC.: SWOT ANALYSIS FIGURE 15 MYRIAD GENETICS, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 16 MYRIAD GENETICS INC.: SWOT ANALYSIS FIGURE 17 F.HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 18 F.HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS FIGURE 19 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT FIGURE 20 ABBOTT LABORATORIES: SWOT ANALYSIS FIGURE 21 GENESIS GENETICS: FINANCIAL OVERVIEW SNAPSHOT FIGURE 22 GENESIS GENETICS: SWOT ANALYSIS FIGURE 23 AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT FIGURE 24 AGILENT TECHNOLOGIES: SWOT ANALYSIS FIGURE 25 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 26 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS FIGURE 27 BUREAU GRAVIMÉTRIQUE INTERNATIONAL: FINANCIAL OVERVIEW SNAPSHOT FIGURE 28 BUREAU GRAVIMÉTRIQUE INTERNATIONAL: SWOT ANALYSIS FIGURE 29 BIO-RAD LABORATORIES INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 30 BIO-RAD LABORATORIES INC..: SWOT ANALYSIS FIGURE 31 ILLUMINA, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 32 ILLUMINA, INC.: SWOT ANALYSIS FIGURE 33 COUNSYL, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 34 COUNSYL, INC.: SWOT ANALYSIS FIGURE 35 ARUP LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT FIGURE 36 ARUP LABORATORIES: SWOT ANALYSIS
    126. Table FIGURE 1 RESEARCH PROCESS FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET FIGURE 4 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY TEST TYPE, 2020 (%) FIGURE 5 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY APPLICATION, 2020 (%) FIGURE 6 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY SETTING TYPE, 2020 (%) FIGURE 7 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 8 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 9 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 10 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 11 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%) FIGURE 12 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET: COMPANY SHARE ANALYSIS, 2020 (%) FIGURE 13 23ANDME, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 14 23ANDME, INC.: SWOT ANALYSIS FIGURE 15 MYRIAD GENETICS, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 16 MYRIAD GENETICS INC.: SWOT ANALYSIS FIGURE 17 F.HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 18 F.HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS FIGURE 19 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT FIGURE 20 ABBOTT LABORATORIES: SWOT ANALYSIS FIGURE 21 GENESIS GENETICS: FINANCIAL OVERVIEW SNAPSHOT FIGURE 22 GENESIS GENETICS: SWOT ANALYSIS FIGURE 23 AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT FIGURE 24 AGILENT TECHNOLOGIES: SWOT ANALYSIS FIGURE 25 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 26 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS FIGURE 27 BUREAU GRAVIMÉTRIQUE INTERNATIONAL: FINANCIAL OVERVIEW SNAPSHOT FIGURE 28 BUREAU GRAVIMÉTRIQUE INTERNATIONAL: SWOT ANALYSIS FIGURE 29 BIO-RAD LABORATORIES INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 30 BIO-RAD LABORATORIES INC..: SWOT ANALYSIS FIGURE 31 ILLUMINA, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 32 ILLUMINA, INC.: SWOT ANALYSIS FIGURE 33 COUNSYL, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 34 COUNSYL, INC.: SWOT ANALYSIS FIGURE 35 ARUP LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT FIGURE 36 ARUP LABORATORIES: SWOT ANALYSIS

    Predictive Genetic Testing & Consumer/Wellness Genomics Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027